Default image


From Pills to Cures: Fall 2022 Kickoff

On September 8, MBG invited Dr. Samarth Kulkarni, CEO of CRISPR Therapeutics, to recount the evolution of CRISPR from its early days, through the clinical stage, and towards the commercialization of a new class of curative medicines. In this event,…